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ABSTRACT 
Objective: To develop a set of quality control procedures for the promising antiviral pharmaceutical substance L-histidyl-1-adamantylethylamine 
dihydrochloride monohydrate, a derivative of rimantadine. 
Methods: Substances and solvents: synthesized in laboratory L-histidyl-1-adamantylethylamine dihydrochloride monohydrate (H-His-
Rim•2HCl•H2O), rimantadine hydrochloride (Rim•HCl), 99%, ethanol 96%, N, N-dimethylformamide (DMF) anhydrous, 99.8% and n-hexane 
anhydrous, 95%, deionized high-resistance water (18.2 MΩ•cm at 25 °C, Milli-Q system), silver nitrate. Infrared (IR) Spectroscopy–Cary 630 Fourier 
Transform IR Spectrometer, elemental analysis–elemental composition analyzer CHNS-O EuroEA3000, ultraviolet (UV) spectrometry–Cary-60 
spectrophotometer, polarimetry–POL-1/2 polarimeter with an external Peltier module, granulometric analysis by optical microscopy (Altami BIO 2 
microscope) and low-angle laser light scattering (LALLS)–Master Sizer 3600, measurement of potential for hydrogen–potentiometer PB-11, 
Spirotox method–the study of temperature dependences of Spirostomum ambiguum lifetime to characterize the biological activity of the studied 
compounds. 
Results: The substance H-His-Rim•2HCl•H2O is an amorphous yellowish powder, slightly soluble in water, soluble in ethanol, freely soluble in N, N-
dimethylformamide, and practically insoluble in n-hexane. A study of the elemental composition has confirmed the authenticity of H-His-
Rim•2HCl•H2O. Comparison of the spectral characteristics of H-His-Rim•2HCl•H2O and Rim•HCl by IR spectroscopy and UV spectrometry confirmed 
the authenticity of the substance. The racemic form of the substance Rim•HCl with an insignificant amount of impurity of the levorotatory 
enantiomer was proved polarimetrically: α =-0.0126±0.0003 (1% aqueous solution, 20±0.5 °С). The specific optical rotation of 1% aqueous solution 
H-His-Rim•2HCl•H2O [α] 
20 = +7.22± 0.06. In 1% ethanol solution [α] 
20 =-10.32±0.12. Using the method of laser light diffraction for a substance H-
His-Rim•2HCl•H2O, the dimensional spectra «fraction of particles, %-d, μm» were characterized, the maximum of which in hexane is in the region of 
40–50 μm. Arrhenius’s kinetics on the Spirotox model established statistically significant differences in ligand-receptor interactions, which are 
characterized by values of observed apparent activation energy °bsEa, kJ/mol: 132.36±1.55 for H-His-Rim•2HCl•H2O and 176.15±0.48 for Rim•HCl. 
Conclusion: The developed set of methods for assessment of physical and chemical properties and biological activity of a new antiviral substance 
H-His-Rim•2HCl•H2O is the basis for establish of regulatory documentation. 
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INTRODUCTION 
The prevention and treatment of seasonal influenza and possible 
pandemic infections require the development of new antiviral drugs 
that are effective against a wide range of influenza strains [1].  
The first effective anti-influenza drugs were the amino derivatives of 
adamantane-rimantadine and amantadine [2, 3]. These compounds 
have been used for the treatment and prevention of influenza A 
since the 1980s. By their mechanism of action, these drugs belong to 
direct inhibitors of the reproduction of the influenza A virus, which 
disrupt the proton-conducting function of the M2 channel of the 
virus [4]. The economic and synthetic availability of adamantane 
derivatives has contributed to their widespread use in controlling 
seasonal influenza epidemics worldwide. However, this led to the 
occurrence of mutations in the M2-protein gene of the influenza 
virus and the loss of antiviral activity of amantadine and 
rimantadine [5]. According to the US Centers for Disease Control and 
Prevention, nearly 100% of influenza viruses are currently 
resistance to amantadine and rimantadine [6]. In this regard, there is 
an active search for new M2-channel inhibitors of the influenza 
virus, mainly adamantane derivatives [7-10]. 
As a result of the search for anti-influenza drugs of the 
adamantane series [11], L-histidyl-1-adamantylethylamine 
dihydrochloride monohydrate (H-His-Rim•2HCl•H2O) was 
synthesized (fig. 1). 
 
Fig. 1: Structural formula of L-histidyl-1-adamantylethylamine 
(b), a derivative of rimantadine (a) 
 
Preclinical in vitro and in vivo studies demonstrated the pronounced 
activity of the new substance against rimantadine and amantadine 
resistant strains of influenza A virus in comparison with other 
analogs [12, 13], which served as the basis for further clinical trials 
of H-His-Rim•2HCl•H2O. The identification of the new substance and 
the determination of its properties are crucial for further testing. 
Some characteristics of the compound (NMR spectrum, mass 
spectrum) were presented previously [14].  
This article is devoted to assessing the properties of a new 
promising antiviral substance H-His-Rim•2HCl•H2O in comparison 
with the known parent substance (Rim•HCl) using a complex of 
physicochemical and biological methods of analysis. The results can 
be used in the development of regulatory documentation for a 
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MATERIALS AND METHODS 
Materials 
The substance H-His-Rim•2HCl•H2O, synthesized in laboratory 
conditions by the classical peptide synthesis method [14], rimantadine 
hydrochloride, 99% (Zhejiang Kangyu Pharmaceutical Co, China), 
ethanol 96% (purity category "Lux"); N, N-dimethylformamide 
anhydrous, 99.8% and n-hexane anhydrous, 95% (Sigma-Aldrich, 
USA); deionized high resistance water (18.2 MΩ•cm at 25 °C, Milli-Q 
system); silver nitrate (chemically pure, Himmed, Russia). 
Methods 
The solubility of substances was determined in accordance with the 
general monograph “Solubility” of the Russia State Pharmacopoeia 
XIV edition [15] in four solvents: deionized high-resistance water, 
ethanol 96%, n-hexane, DMF. 
The analysis of substances in the mid-infrared region was carried 
out using a Cary 630 Fourier transform IR spectrometer (Agilent 
Technologies, USA) with an attenuated total reflection (ATR) 
attachment.  
To analyze the elemental composition of H-His-Rim•2HCl•H2O and 
Rim•HCl used the analyzer CHNS-O EuroEA3000 (Eurovector, S. p. 
A., Italy) [16]. 
The optical density of substance solutions in water, ethanol and DMF 
in the UV region was measured on a Cary-60 spectrophotometer 
(Agilent Technologies, USA). 
The optical activity of the compounds was determined on a POL-1/2 
polarimeter with an external Peltier module for temperature control 
(Atago Co., LTD, Japan). The solutions in water and ethanol (1%) 
were analyzed at 25 °C. The length of the polarimeter tube is 1 dm. 
The size and shape of the substance particles were determined by 
optical microscopy method (microscope Altami BIO 2, Russia) with a 
10-fold increase. The sample was applied to the slide and distributed 
evenly over the entire surface. The particles were observed in 10 
separate fields of vision.  
Granulometric analysis of the samples was carried out by the 
method of low-angle laser light scattering [17] with the Mastersizer 
3600 (Malvern Panalytical, United Kingdom).  
The potential for hydrogen of aqueous solutions of compounds was 
measured by the potentiometric method (Basic Meter PB-11, 
Sartorius, Germany) [15]. Buffer solutions with pH 4.0, 7.0 and 10.0 
prepared from standard titer were used for calibration. 
Spirostomum ambiguum test culture was used to study the biological 
activity of substances by the Spirotox method [18]. Equipment: 5-
well thermostatic plate, Alpha A6 thermostat (Lauda, Germany), 
MBS-10 binocular, daylight lamp (~ 10 W). 
Statistical processing and graphical representation of the results were 
carried out using Origin Pro 9.1 software (OriginLab Corporation, 
USA). Statistical processing consisted in calculating the mean±SD. 
RESULTS AND DISCUSSION 
For substances synthesized in laboratory conditions, first of all, it is 
necessary to establish the chemical structure and prove its identity 
to the target compound. Earlier, for this purpose, we used NMR 
spectroscopy and mass spectrometry, which confirmed the structure 
of the synthesized compound H-His-Rim•2HCl•H2O [13]. The 
presence of 2 moles of hydrochloric acid per 1 mole of the salt form 
was confirmed by the reaction to chloride ions with a solution of 
silver nitrate [15].  
In addition, C, H, N ratios were determined (Dumas-Pregle method) 
for the parent substance Rim•HCl and the target rimantadine 
derivative H-His-Rim•2HCl•H2O by the elemental analysis method 
(table 1). 
The results confirm the authenticity of both substances and indicate 
an acceptable purity of the substances. In the case of H-His-
Rim•2HCl•H2O, a slight difference in the nitrogen and hydrogen 
contents from the calculated one may be due to the presence of 
concomitant impurities. 
Solubility 
The solubility of a pharmaceutical substance is an important 
characteristic that determines the purity, rate of release of the active 
pharmaceutical ingredient (API) from the finished dosage form, its 
absorption into the bloodstream, and the achievement of a 
therapeutic effect. The solubility of both substances was evaluated in 
different solvents (table 2), which made it possible to compare their 
lipophilicity.
 
Table 1: The results of elemental analysis of the substances H-His-Rim•2HCl•H2O and Rim•HCl 
Element H-His-Rim•2HCl•H2O Rim•HCl 
Calculated value, % Obtained value, % Calculated value, % Obtained value, % 
C 53.10 53.58±0.31 66.81 66.87±0.07 
H 7.93 8.30±0.23 10.28 10.48±0.20 
N 13.75 12.86±0.16 6.49 6.58±0.19 
mean±SD, n= 3, P=0.90 
 
Table 2: Solubility of H-His-Rim•2HCl•H2O and Rim•HCl in various solvents 
Solvent The volume of solvent (ml) to dissolve 1 g of the substance 
Rim•HCl H-His-Rim•2HCl•H2O 
H2O 20 200 
C2H5OH 20 20 
DMF 10 10 
n-hexane >1000 >1000 
 
Thus, using conventional solubility terms, H-His-Rim•2HCl•H2O can 
be characterized as a compound that is slightly soluble in water 
(1:200), soluble in ethanol 96% (1:20), freely soluble in DMF (1:10) 
and practically insoluble in n-hexane (>1:1000). The observed 
differences in water solubility compared to Rim•HCl indicate higher 
lipophilicity of the new substance due to the introduction of an 
additional fragment into the molecule (fig. 1). 
Infrared spectroscopy 
To determine the authenticity of substances, the attenuated total 
reflection Fourier transform infrared spectroscopy (ATR-FTIR) 
method was also used (fig. 2). 
The analysis of the IR spectra of the two studied substances showed 
the presence of absorption bands corresponding to both the general 
structural fragments and the functional groups introduced into the 
H-His-Rim•2HCl•H2O (table 3), e. g. the amide group (-NH-CO-). For 
both substances, there are several pronounced absorption bands in 
the region 2900–2800 cm-1, which correspond to valence vibrations 
of the C-H bond in the-CH3 and-CH2 groups of the adamantane cycle 
and the linear carbon chain. Both substances also contain a primary 
aliphatic amino group in their structure. The presence of absorption 
bands in the spectrum of H-His-Rim•2HCl•H2O in the region of 3300-
3200 cm-1 indicates the presence of the-NH2 free group. Its partial 
protonation is explained by the fact that there are three additional 
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nitrogen atoms in the molecule with free electron pairs. This leads to 
the appearance of absorption bands in the region of 2000-2500 cm-1. 
In the case of Rim•HCl, there are no absorption bands typical for a 
free amino group, and the presence of absorption bands at 3036, 
2507, 2030 cm-1 indicates the presence of a protonated amino group 
(−NH3
), which confirms the presence of Rim•HCl in the salt form. 
 
 
Fig. 2: ATR-FTIR spectra of H-His-Rim•2HCl•H2O and Rim•HCl 
 
Table 3: The main absorption bands in the ATR-FTIR spectrum of H-His-Rim•2HCl•H2O (ν–valence vibration, δ–deformation vibration) 
Wavenumber, cm-1 Type of vibrations and functional group 
3303, 3249 νN-H (-NH2) 
3083 νN-H (-NH-CO-) 
2897 νC-H (-CH3) 
2848 νC-H (-CH2) 
2766, 2701 νN-H (−	
2
) 




1558 δN-H (-NH-CO-) 
 
Thus, the infrared spectroscopy method allowed to confirm the 
structural features of the compounds. 
Ultraviolet-visible spectroscopy 
Electronic spectra of substances solutions in 96% ethanol (fig. 3) 
were used for their identification. 
In 0.5% Rim•HCl alcohol solution, there are two absorption bands with 
maximums at 230 nm and 256 nm wavelength and minimum at 246 nm. 
One absorption band with a maximum at 216 nm is observed on the 
spectrum of 0.01% alcohol solution of H-His-Rim•2HCl•H2O.  
The UV spectra of both substances in DMF are characterized by 
identical absorption bands with a maximum of about 270 nm, 
although they differ in their molar attenuation coefficients (fig. 4). 
Using the formula of the Beer-Lambert–Bouguer law, the molar 
attenuation coefficient (ε) of solutions in DMF was determined. ε 
(Rim•HCl) = 18.12 L•mol-1•cm-1, ε (H-His-Rim•2HCl•H2O) = 4073.70 
L•mol-1•cm-1. An increase in the molar attenuation coefficient of H-
His-Rim•2HCl•H2O is associated with the appearance of new 
chromophore groups in the molecule. 
Polarimetry 
The presence of chiral carbon atoms in the test compounds 
indicates their optical activity. One asymmetric carbon atom is 
present in the Rim•HCl molecule, 2 chiral centers are 
characteristic of the H-His-Rim•2HCl•H2O molecule. The location 
of chiral carbon atoms in the molecules of the studied substances 
is shown in fig. 5. 
 
 
Fig. 3: UV spectra of alcohol solutions 0.5% Rim•HCl (А) and 0.01% H-His-Rim•2HCl•H2O (В) 
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Fig. 4: UV spectra of solutions of 0.5% (0.023 mol/l) Rim•HCl (А) and 0.01% (0.245 mmol/l) H-His-Rim•2HCl•H2O (В) in DMF 
 
 
Fig. 5: Location of chiral centers in H-His-Rim•2HCl•H2O (b) and Rim•HCl (a) molecules, the measured optical rotation (α) and the 
calculated values of the specific optical rotation ([]
) for 1% solutions of substances are shown in table 4. 
 
Table 4: Optical activity of 1% aqueous solutions of Rim•HCl and H-His-Rim•2HCl•H2O 




H-His-Rim•2HCl•H2O +0.0722±0.0006 +7.22±0.06 -0.1032±0,0012 -10.32±0.12 
Rim•HCl -0.0126±0.0003 -1.26±0.03 -0.0133±0.0007 -1.33±0.07 
mean±SD, n= 5, P=0.90 
 
Since the substance of rimantadine is a racemate, the optical rotation 
was close to zero in both solvents. The optical rotation of H-His-
Rim•2HCl•H2O depends on the solvent nature, both in absolute 
value and in sign. 
Optical microscopy 
The shape and size of the particles, as well as the state of their surface, 
have a significant impact on the development and production of drugs 
of proper quality, including the release of APIs from the dosage form 
[19]. Granulometric analysis of the substance (fig. 6) showed that 
particles of 20–40 μm (47%) and 40–60 μm (27%) prevailed in it. 
The particles are irregularly shaped, roughened. The presence of 
many small particles indicates a low strength of large 
conglomerates. The predominance of small particles facilitates the 
release of API from the dosage form and increases bioavailability. 
Low-angle laser light scattering 
To determine the particle size of the substance, the laser 
obscuration parameter was used, which characterizes the loss of 
light intensity as a result of reflection, absorption, and 
diffraction processes.  
The particle size distribution of the substance H-His-Rim•2HCl•H2O 
was carried out in n-hexane to exclude the process of sample 
dissolution. The substance is represented by a wide distribution 
band in the range from 10 to 120 μm with a maximum of the size 
group d = 50 μm and a shoulder at d = 70 μm (fig. 7). 
 
 
Fig. 6: Granulometric composition (a) and visualization of H-His-Rim•2HCl•H2O (b) particle size and shape (b) by optical microscopy 
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Fig. 7: Determination of H-His-Rim•2HCl•H2O powder particle 
distribution by laser diffraction analysis in n-hexane 
The size spectrum obtained by the LALLS method correlates with 
the results of optical microscopy (fig. 6). 
Potentiometry 
The pH was measured at 25 °C for 1% aqueous solutions of H-His-
Rim•2HCl•H2O and Rim•HCl in triplicate. pH (Rim•HCl) = 4.40±0.11, 
pH (H-His-Rim•2HCl•H2O) = 3.15±0.09. The results obtained 
confirm that the compounds are the salt form of the strong acid HCl, 
while H-His-Rim•2HCl•H2O is bound to 2 HCl molecules, which 
confirms a lower pH value. 
Spirotox method 
Protozoa, in particular, Spirostomum ambiguum, are widely used as 
test objects for toxicological and pharmacological studies of API [20, 
21]. The death rate of a unicellular organism depends on the 
temperature of the environment, nature, and the concentration of 
the API.  
To estimate the biological activity of H-His-Rim•2HCl•H2O and 
Rim•HCl compounds, the temperature dependence of S. ambiguum 
death in the range of 299-305 K in increments of 2 K was analyzed 
(fig. 8, 9). 
 
 
Fig. 8: Dependence of life span of S. ambiguum on temperature in 0.025% (1.16 mmol/l) aqueous solution of Rim•HCl in straight (A) and 
Arrhenius (B) coordinates (mean±SD, n=5, Р=0.90) 
 
 
Fig. 9: Dependence of life span of S. ambiguum on temperature in 0.025% (0.61 mmol/l) aqueous solution of H-His-Rim•2HCl•H2O in 
straight (A) and Arrhenius (B) coordinates (mean±SD, n=5, Р=0.90) 
 
The observed apparent activation energy ( °bsEa) values for the test compounds were found using Arrhenius coordinates (table 5). 
 
Table 5: The calculated °bsEa values of ligand-induced S. ambiguum death process in aqueous solutions of H-His-Rim•2HCl•H2O and 
Rim•HCl 
API  °bsEa, kJ/mol 
H-His-Rim•2HCl•H2O 132.36±1.55 
Rim•HCl 176.15±0.48 
mean±SD, n=5, Р=0.90 
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The value of °bsEa reflects the ligand-receptor interaction 
accompanied by cell death. The lower activation energy, as well as 
the reduction of S. ambiguum lifetime by about 2 times at the same 
temperature for H-His-Rim•2HCl•H2O compared to Rim•HCl, 
indicates a higher biological activity of this compound. 
CONCLUSION 
The compound H-His-Rim•2HCl•H2O–is a promising anti-influenza 
drug for which the antiviral activity in vitro and in vivo has 
previously been confirmed in laboratory animals. For subsequent 
clinical trials, it is important to have regulatory documentation that 
allows quality control of the new promising substance. The results 
obtained in this study are the basis for the development of a 
pharmacopeia monograph for a new antiviral substance. 
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